OKYO Pharma Limited Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019
OKYO Pharma Limited (OKYO) reported Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019 of $4.18 per share for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-18.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 · last filed 2025-07-18
| Period end | Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019 12 month | Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019 12 month as first filed |
|---|---|---|
| 2025-03-31 | $4.18 20-F · filed 2025-07-18 | |
| 2024-03-31 | $2.13 20-F · filed 2025-07-18 | |
| 2022-03-31 | $3.84 20-F · filed 2024-08-13 | $5.91 20-F · filed 2022-08-15 |
| 2021-03-31 | $6.21 20-F · filed 2023-08-15 | |
| 2020-03-31 | $5.58 20-F · filed 2022-08-15 |